Our Team at CPHI Frankfurt 2025
About Anthea Pharma
Anthea Pharma, established in 2019 is a young, R&D focused Injectables firm, backed by the prestigious Yashoda Group. Based out of Hyderabad, India, Anthea Pharma has a world class R&D facility, and an injectable manufacturing facility, currently capable of manufacturing liquid Vials, Emulsions, PFS, Lyophilized Vials and Ampoules. Anthea Pharma envisions to manufacture for the world and be a global firm focused on injectables needs with consistent supply of highest-quality products across therapeutic segments. Our deep relationships in the healthcare and life science segment has enabled us to secure the backing of Yashoda Group, weaving a compelling blend of Hospitals, Pharmaceuticals, and Real Estate.
About CPHI Frankfurt 2025
CPHI Frankfurt is a global pharmaceutical event uniting the pharmaceutical community to advance human health. With a history spanning 35 years, the event has become a cornerstone for fostering connections and inspiring partnerships across the industry. CPHI Frankfurt is a platform for professionals to engage with the latest innovations, share knowledge, and collaborate on projects that shape the future of pharmaceuticals.
Key Highlights of CPHI Frankfurt 2025:
Global Participation: The event expects to welcome 62,000 attendees and 2,400 exhibitors from 166+ countries,demonstrating its significant international reach.
Diverse Exhibition: Attendees can explore a wide range of products and services across various pharmaceutical sectors.
Networking Opportunities: CPHI Frankfurt offers numerous opportunities for attendees to connect, build relationships, and forge partnerships.
Knowledge Exchange: The event features conferences, seminars, and workshops where industry experts share insights and discuss the latest trends.
Celebration of 36 Years: CPHI Frankfurt 2025 marks a special milestone, celebrating 36 years of uniting the pharma community.







